Mathias Freitag

Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.

Christoph Bode, G. Meinhardt, M S Runge et al. · Circulation · 1991 · 71 citations · Full text

Medicine, Cardiology, Pharmacology +17

A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.

M S Runge, Thomas Quertermous, P J Zavodny et al. · Proceedings of the National Academy of Sciences · 1991 · 63 citations

Life Sciences, Biochemistry, Molecular Biology +17

Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.

Christoph Bode, M Hudelmayer, P Mehwald et al. · Circulation · 1994 · 44 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Hemocompatibility of PMEA Coated Oxygenators Used for Extracorporeal Circulation Procedures

Anja K. Zimmermann, Hermann Aebert, Andrea Reiz et al. · ASAIO Journal · 2004 · 40 citations

Medicine, Bioengineering, Biomedical Engineering +17

CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study

Katja S. Just, Harald Dormann, Mathias Freitag et al. · Frontiers in Pharmacology · 2021 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17